Finance » Insurance

6 thru 15 of 149 Stories

GOP Bill would Undermine Auto, Rail Safety Regulations

By Joan Lowy, Tom Krisher | Jul 17
At a time of record auto recalls and high-profile train wrecks, Republicans are working on legislation to roll back safety regulation of the auto and railroad industries.

Blue Cross and Blue Shield to Offer ID Protection Services

Jul 16
Blue Cross and Blue Shield will be providing identity protection services to all eligible members across the U.S. by the start of the new year.

Pricey Successor Overtakes $1,000-Per-Pill Hepatitis C Drug

By Ricardo Alonso-Zaldivar | Jul 15
The $1,000 pill for a liver-wasting viral infection that made headlines last year is no longer the favorite of patients and doctors. The new leading pill for hepatitis C is more expensive, and the number of patients seeking a cure has surged.

A New Shoe that Grows for Children

Jul 15
"Because International" is a nonprofit that has developed a new children's shoe that expands up to five sizes.

US Women Buying Street Grade Heroin at Rock Bottom Prices

Jul 13
A CDC report shows a 63 percent increase in heroin use over the last decade.

Doctor Misdiagnosed Cancer to Profit from Treatments

Jul 9
Cancer specialist Dr. Farid Fata sat in a Michigan courtroom and listened to former patients describing how he ruined their lives.

Medicare Proposes Coverage Change on Short Hospital Stays

By Richardo Alonso-Zaldivar | Jul 3
Medicare proposed to ease a coverage policy on short hospital stays that has been criticized because it can result in higher costs for seniors.

Health Ruling Relieves Consumers; GOP States Remain Critical

By Kelly Kennedy | Jun 26
The Supreme Court ruling validating federal health insurance subsidies for nearly 6.4 million Americans had consumers breathing a sigh of relief, but the reaction was different states states that have fought against the Affordable Care Act.

Doctors Propose Tool to Help Gauge the Value of Cancer Drugs

By Marilynn Marchione | Jun 24
The pushback against soaring cancer drug prices is gaining steam. A leading doctors group proposed a formula to help patients decide if a medicine is worth it - what it will cost them and how much good it is likely to do.

Anthem Reaffirms Commitment to Its $47-Billion Bid for Cigna

By Tom Murphy | Jun 23
Anthem sees its more than $47 billion bid to buy rival Cigna as a way to muscle up on technology that helps consumers and to strengthen its rapidly growing Medicare Advantage business.

6 thru 15 of 149 Stories